The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2025 for Hima Bindu Potluri
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hima Bindu Potluri, a promoter of SMS Pharmaceuticals Ltd, filed a disclosure under SEBI SAST Regulations regarding changes in encumbrance of shares. On 19 August 2025, 30 lakh equity shares were released from a Non-Disposal Undertaking (NDU). On 20 August 2025, the same 30 lakh shares were pledged, with Annexure-II indicating this is connected to a debt instrument. The net effect is neutral in terms of share count — the encumbrance was simply restructured from an NDU into a pledge, with no change in the total number of encumbered shares held by the promoter.
No change in the promoter's overall encumbered position, but the shift from NDU to pledge suggests a new loan or debt obligation backed by these shares. Shareholders should watch for any further disclosures on the purpose of the debt and whether more shares are pledged in the future.